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Aging-Associated miR-217 Aggravates 
Atherosclerosis and Promotes Cardiovascular 
Dysfunction
Virginia G. de Yébenes , Ana M. Briones, Inmaculada Martos-Folgado, Sonia M. Mur, Jorge Oller, Faiz Bilal,  
María González-Amor , Nerea Méndez-Barbero, Juan Carlos Silla-Castro , Felipe Were, Luis J. Jiménez-Borreguero ,  
Fátima Sánchez-Cabo, Héctor Bueno, Mercedes Salaices, Juan Miguel Redondo, Almudena R. Ramiro
OBJECTIVE: microRNAs are master regulators of gene expression with essential roles in virtually all biological processes. miR-
217 has been associated with aging and cellular senescence, but its role in vascular disease is not understood.
APPROACH AND RESULTS: We have used an inducible endothelium-specific knock-in mouse model to address the role of miR-
217 in vascular function and atherosclerosis. miR-217 reduced NO production and promoted endothelial dysfunction, 
increased blood pressure, and exacerbated atherosclerosis in proatherogenic apoE−/− mice. Moreover, increased endothelial 
miR-217 expression led to the development of coronary artery disease and altered left ventricular heart function, inducing 
diastolic and systolic dysfunction. Conversely, inhibition of endogenous vascular miR-217 in apoE−/− mice improved vascular 
contractility and diminished atherosclerosis. Transcriptome analysis revealed that miR-217 regulates an endothelial signaling 
hub and downregulates a network of eNOS (endothelial NO synthase) activators, including VEGF (vascular endothelial 
growth factor) and apelin receptor pathways, resulting in diminished eNOS expression. Further analysis revealed that human 
plasma miR-217 is a biomarker of vascular aging and cardiovascular risk.
CONCLUSIONS: Our results highlight the therapeutic potential of miR-217 inhibitors in aging-related cardiovascular disease.
GRAPHIC ABSTRACT: A graphic abstract is available for this article.
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Cardiovascular disease (CVD) is the leading cause of death in the Western world (http://www.who.int/cardiovascular_diseases/resources/atlas/en/), 
and the major risk factor for CVD is aging. CVD affects 
around 40% of people aged between 40 and 60 years 
and >80% of those aged over 85 years,1 with the most 
prevalent conditions being heart failure, hypertension, 
and coronary artery disease. A key determinant of the 
development of these CVD syndromes is the aging of the 
vasculature.2 The molecular pathways underlying vascu-
lar aging are not fully understood; however, it is known 
that one of the major contributors to atherosclerosis and 
CVD development is endothelial dysfunction.3
MicroRNAs (miRNAs) are small noncoding RNA 
molecules that fine-tune cellular homeostasis through 
the posttranscriptional control of gene networks. 
miRNAs play crucial roles in cardiovascular tissue 
homeostasis and disease, and there is growing inter-
est in the development of miRNA-targeted therapies 
for CVD.4,5 Reduction or loss of the pre-miRNA pro-
cessing enzyme Dicer in vivo disrupts various aspects 
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endothelial growth, demonstrating the relevance of 
miRNAs to endothelial function.6–8 Several studies 
have characterized the function of specific miRNAs 
that modulate endothelial cell physiology.9 miR-217 
was identified as the most highly induced miRNA dur-
ing in vitro human endothelial cell aging, resulting in 
the downregulation of the expression of Sirt1 (silent 
information regulator 1).10 Sirt1 is an NAD+-dependent 
deacetylase that regulates gene expression and plays 
an important role in longevity through the regulation of 
metabolic adaptation and cardiovascular protection.11 
In endothelial cells, Sirt1 activates eNOS (endothe-
lial NO synthase).12 eNOS-derived NO plays crucial 
roles in the regulation of vascular tone, cell prolifera-
tion, leukocyte adhesion, and platelet aggregation.13,14 
However, knowledge remains limited about the patho-
physiological impact of miR-217 expression on endo-
thelial cells in vivo and the effect of miR-217 on the 
endothelial transcriptome.
In the present study, we used gain- and loss-of-func-
tion strategies to modify miR-217 expression in mice 
and thus decipher the impact of miR-217 on cardiovas-
cular physiology and pathology. Transcriptome analysis 
showed that endothelial miR-217 expression is a master 
regulator of vascular signaling and decreases various 
eNOS stimulatory pathways. Accordingly, we found that 
miR-217 reduces NO production, promotes atheroscle-
rosis, and impairs cardiovascular function. Moreover, we 
found increased miR-217 in human plasma from aged 
individuals and CVD patients. Our results thus reveal 
miR-217 as a promising therapeutic target and a novel 
biomarker of cardiovascular aging.
EXPERIMENTAL PROCEDURES
Mice
Endothelial-specific inducible miR-217 C57BL/6J knock-in 
mice were generated by crossing Rosa26 miR-217 knock-
in mice15 with the endothelium-specific tamoxifen-inducible 
VE-Cad (VE-cadherin) CreERT2 line.16 miR-217KI/+ VE-Cad 
CreERT2TG/+ mice (miR-217 mice) were crossed to the apoE−/− 
C57BL/6J proatherogenic background and fed a high-fat diet 
(HFD) containing 10.7% total fat and 0.75% cholesterol (Ssniff 
Spezialdiäten) for 7 to 12 weeks when indicated. In both mod-
els, Cre expression was induced by intraperitoneal administra-
tion of tamoxifen (1 mg tamoxifen/mouse for 5 consecutive 
days). When indicated, resveratrol was administrated during 
1 week in drinking water at 1 mg/mL (400 mg/kg per day). 
In adherence to Arteriosclerosis, Thrombosis, and Vascular 
Biology Council guidelines, endothelium-dependent NO pro-
duction, vessel contractility, and atherosclerosis studies were 
performed with groups of animals of the same sex, given that 
sex difference is a biological variable in these studies. All other 
studies were performed with equally distributed sex-matched 
experimental groups. Animal procedures were approved by 
the Centro Nacional de Investigaciones Cardiovasculares 
Ethics Committee and the Madrid regional authorities (PROEX 
377/15) and conformed to EU Directive 2010/63EU and 
Recommendation 2007/526/EC regarding the protection of 
animals used for experimental and other scientific purposes, 
enforced in Spanish law under Real Decreto 1201/2005.
Human Samples
Plasma from 41 disease-free nonagenarian individuals and 
from 42 healthy women aged <50 years and not diagnosed 
with any relevant disease and representative of the Spanish 
population was obtained from the Banco Nacional de ADN 
Carlos III-Salamanca University Biobank (http://www.banco-
adn.org/en). Plasma samples from 32 patients diagnosed with 
coronary atherosclerosis and 34 age- and sex-matched healthy 
control individuals were obtained with informed consent at the 
Hospital Universitario 12 de Octubre (Madrid). The use of 
human samples in this project was approved by the Instituto 
de Salud Carlos III Ethics Committee (CEI PI 23_2017) and by 
Nonstandard Abbreviations and Acronyms
ADCY2 adenylate cyclase 2
APLNR apelin receptor
BMI body mass index
BP blood pressure
CVD cardiovascular disease





LPAR lysophosphatidic acid receptor
miR-217SPG miR-217 sponge construct
miRNA microRNA
MLEC mouse lung endothelial cell
NOS NO synthase
Sirt1 silent information regulator 1
TNFα tumor necrosis factor-alpha
VE-Cad VE-cadherin
VEGF vascular endothelial growth factor
VEGFR  vascular endothelial growth factor 
receptor
Highlights
• miR-217 promotes endothelial dysfunction, aggra-
vates atherosclerosis, and promotes cardiovascular 
dysfunction.
• miR-217 regulates a hub of endothelial functions 
and triggers a coordinated dampening of eNOS 
(endothelial NO synthase) signaling pathways.
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the Institutional Review Board at the Instituto de Investigación 
Hospital 12 de Octubre (imas12; CEI 16/044).
Primary Mouse Lung Endothelial Cell Isolation 
and Culture
Lung endothelial cells were extracted from wild-type 
C57BL/6J mice. Lungs were disaggregated with 0.1% colla-
genase (Roche). Lung cell suspensions were seeded on a gel-
atin-collagen coated matrix (Sigma) and cultured for 24 hours 
in DMEM/F-12 supplemented with 20% fetal calf serum and 
bovine brain endothelial cell growth factor. Cells were then har-
vested, depleted of macrophages by negative magnetic selec-
tion with rat anti-mouse CD16/CD32 (cluster of differentiation 
16/cluster of differentiation 32) antibody (BD Pharmingen) 
and sheep anti-rat IgG dynabeads (Invitrogen), and cultured for 
48 hours. Mouse lung endothelial cells (MLECs) were isolated 
by positive magnetic selection using rat anti-mouse ICAM-2 
(intercellular adhesion molecule 2) antibody (BD Pharmingen) 
and sheep anti-rat IgG dynabeads.
Cell Culture of Human Vein Endothelial Cells
Primary human vein endothelial cells were seeded on a gelatin-
coated matrix (Sigma) and cultured for 3 days in DMEM/F-12 
supplemented with 20% fetal calf serum, bovine brain endo-
thelial cell growth factor, and different doses (from 0 to 100 
µM) of resveratrol (Invivochem).
RNA Isolation and Real-Time Polymerase Chain 
Reaction
RNA was extracted with Trizol (Invitrogen) from cells or 
ultra-turrax disrupted aorta. RNA was extracted from plasma 
or serum with the miRCURY RNA biofluids isolation kit 
(Exiqon). For quantitative real-time polymerase chain reac-
tion, total RNA was converted to cDNA using random primers 
(Roche), reverse transcribed with SuperScript II (Invitrogen), 
and analyzed by SYBR Green assay (Applied Biosystems) 
with mouse-specific primers: Sirt1 (forward) 5′-tgtgaagttact-
gcaggagtgtaaa-3′, (reverse) 5′-gcatagataccgtctcttgatctgaa-3′; 
TNFα (tumor necrosis factor-alpha; forward) 5′-agcccacgtcg-
tagcaaacca-3′, (reverse) 5′-acaacccatcggctggcacc-3′; IL (inter-
leukin)-6 (forward) 5′-gaaaatctgctctggtcttctgg-3′, (reverse) 
5′-ttttctgaccacagtgaggaatg-3′; IL-1Rα (forward) 5′-tagacatg-
gtgcctattgacct-3′, (reverse) 5′-tcgtgactataaggggctcttc-3′; Icam 
(forward) 5′-cgctgtgctttgagaactgtg-3′, (reverse) 5′-atacacggt-
gatggtagcgga-3′; Aplnr (forward) 5′-ccttaccacctggtgaagac-3′, 
(reverse) 5′-aggtgcagtacggaaagac-3′; VEGF (vascular 
endothelial growth factor) R1 (forward) 5′-acagaaggagag-
cagaagtc-3′, (reverse) 5′-cttcatcgttacagcagcc-3′; VEGFA 
(forward) 5′-acagaaggagagcagaagtc-3′, (reverse) 5′-cttcatc-
gttacagcagcc3′; Lpar (lysophosphatidic acid recep-
tor)-1 (forward) 5′-gaaagcaagcatgtggtgtg-3′, (reverse) 
5′-cactctttgggtgacaagctc-3′; Adcy2 (adenylate cyclase 2; 
forward) 5′-ctttggagggaccgtgtctg-3′, (reverse) 5′-ccctcatgtt-
gaagggaagc-3′; Nos3 (forward) 5′-atcacctacgacaccctcag-3′, 
(reverse) 5′-cggctctgtaacttccttgg-3′. Gapdh was used as a 
normalization control: (forward) 5′-tgaagcaggcatctgaggg-3′, 
(reverse) 5′-cgaaggtggaagagtgggag-3′. Human specific prim-
ers: SIRT1 (forward) 5′-cttcgcaactatacccagaac-3′, (reverse) 
5′-cctcgtacagcttcacagtc-3′; NOS (NO synthase) 3 (forward) 
5′-ctcatgggcacggtgatg-3′, (reverse) 5′-accacgtcatactcatc-
catacac-3′; GAPDH (forward) 5′-gaaggtgaaggtcggagtc-3′, 
(reverse) 5′-gaagatggtgatgggatttc-3′. For mature miR-217 
quantification, RNA was converted to cDNA with the miR-
CURY LNA Universal RT kit (Exiqon). miR-217 was quantified 
with miR-217 miRCURY LNA primers (Exiqon). The presence 
of miR-217 was considered positive in samples in which all 
technical triplicates amplified before cycle 40. The normaliza-
tion control for samples extracted from cells or tissue was U6. 
The normalization controls for serum and plasma samples were 
miR-16 and UniSp6 spike-in (Exiqon).
Immunohistochemistry
Mouse aortas were perfused with saline solution, cleaned under 
a microscope, excised, and fixed in formalin for 2 days before 
being embedded in paraffin blocks. Aortic cross sections were 
stained with antibodies against GFP (green fluorescent pro-
tein; Acris Antibodies) and CD31 (Abcam). GFP immunohisto-
chemistry was quantified in the aorta intima using Tissuemorf 
software (Viopharm).
Isometric Tension Studies
Mice were euthanized by CO2 inhalation. The aorta and first-
order mesenteric artery branches were removed and placed 
in cold (4°C) Krebs-Henseleit solution (KHS; 115 mmol/L 
NaCl, 25 mmol/L NaHCO3, 4.7 mmol/L KCl, 1.2 mmol/L 
MgSO4.7H2O, 2.5 mmol/L CaCl2, 1.2 mmol/L KH2PO4, 
11.1 mmol/L glucose, and 0.01 mmol/L Na2EDTA) bubbled 
with a 95% O2-5% CO2 mixture (pH=7.4). Ring segments 
of mouse aorta and mesenteric arteries, ≈2 mm in length, 
were mounted in a small vessel chamber myograph (Danish 
Myotechnology) for the measurement of isometric tension. 
Two tungsten wires (40-mm diameter) were introduced 
through the lumen of the segments. After a 30-minute 
equilibration period in oxygenated KHS, arterial segments 
were stretched to their optimal lumen diameter for active 
tension development. Segment contractility was then tested 
with an initial exposure to high-K+ solution (K+-KHS: KHS 
containing 120 mmol/L KCl). The presence of endothelium 
was determined by the ability of 10 µmol/L acetylcholine 
to relax arteries precontracted with phenylephrine at ≈50% 
K+-KHS contraction. Afterward, a single concentration-
response curve was recorded in response to acetylcholine 
(1 nmol/L to 30 µmol/L), phenylephrine (1 nmol/L to 0.1 
mmol/L), and diethylamine NONOate (1 nmol/L to 30 
µmol/L). In some experiments, L-NAME (Nω-nitro-L-arginine 
methyl ester; 100 µmol/L) was added 30 minutes before 
recording the phenylephrine concentration-response curves.
All drugs were dissolved in distilled water. Phenylephrine 
hydrochloride (catalog No. P6126), acetylcholine chloride 
(catalog No. A9101), diethylamine NONOate (catalog No. 
D5431), and L-NAME (catalog No. N5751) were purchased 
from Sigma-Aldrich.
Vasoconstrictor responses are expressed as a percentage 
of the tone generated by K+-KHS. Vasodilator responses are 
expressed as the percentage of the previous tone induced by 
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Quantification of NO Production
After equilibration for 60 minutes in HEPES buffer at 37°C, 
aortic segments were incubated for 45 minutes with the 
fluorescent probe 4,5-diaminofluorescein (2 µmol/L; Sigma-
Aldrich; catalog No. D225). The medium was collected to mea-
sure baseline NO release, and the segments were incubated 
with phenylephrine (1 µmol/L, 5 minutes) and acetylcholine 
(10 µmol/L, 10 minutes). Thereafter, the medium was collected 
to measure agonist-induced NO release. Medium fluorescence 
was measured at room temperature using a spectrofluorimeter 
at an excitation wavelength of 492 nm and emission wave-
length of 515 nm. To control for day-to-day fluorescence fluc-
tuations, all experimental parameters were measured every 
day. NO release was calculated by subtracting baseline NO 
release from that evoked by acetylcholine. Blank samples were 
collected in the same way from segment-free medium to cor-
rect for background emission. The amount of NO released was 
expressed in arbitrary units/min·µg−1 protein. Variations in NO 
release were calculated as a percentage relative to controls.
Blood Pressure Measurements in Mice
Arterial blood pressure (BP) was measured in mouse tails 
using the automated BP-2000 Blood Pressure Analysis 
System (Visitech Systems). BP measurements were recorded 
with the tail-cuff method in restrained mice kept on a warmed 
37°C surface. Before recording BP, mice were trained on the 
equipment over 5 consecutive days. After the training period, 
BP was measured in 3 independent aged-matched cohorts of 
HFD-fed mice. Twenty consecutive systolic and diastolic BP 
measurements were performed per mouse, and the last 10 
readings were recorded and averaged.
Atherosclerosis Development Quantification
Atherosclerosis development was quantified in oil red 
O–stained aortic root heart cross sections from HFD-fed 
control and miR-217 gain- and loss-of-function apoE−/− mice. 
Saline-perfused hearts were fixed for 2 hours in 4% parafor-
maldehyde, embedded in optimal cutting temperature tissue 
embedding compound, and frozen at −80°C. Atherosclerotic 
plaque area and volumes were quantified by ImageJ analysis of 
oil red O–stained serial 80-µm spaced cryostat cross sections 
of aortic root, starting from the aortic sinus. Atherosclerosis 
plaque volume was calculated as the area under the curve in 
plots that quantify atherosclerosis lesion area through the aor-
tic sinus and ascending aorta for each condition, as explained in 
detail in.17 The necrotic core within atherosclerotic lesions was 
quantified from Masson trichrome–stained cryostat cross sec-
tions as the area lacking extracellular matrix (total loss of col-
lagen). Atherosclerotic plaques in the left coronary artery were 
quantified from oil red O–stained aortic root cryosections of 
HFD-fed control and miR-217 apoE−/− mice. Methods adhered 
to the American Heart Association guidelines for experimen-
tal atherosclerosis studies, which include recommendations for 
randomization, blinding, and data handling.
Immunofluorescence
For tissue immunofluorescence, hearts were fixed with 4% 
paraformaldehyde, incubated with 30% sucrose, embedded in 
optimal cutting temperature compound (Olympus), and frozen on 
dry ice. Ten-micrometer sections were permeabilized with 0.5% 
Triton X-100 (Sigma) and blocked with 2% BSA (Sigma) and 5% 
normal serum (Sigma) and stained with the following antibod-
ies: anti-SMA-1 (smooth muscle actin-1) biotin (ThermoFisher 
Scientific), anti-MAC-2 (galectin 3; TebaBio), anti-CD68 
(Serotec MCA1957), anti-VCAM-1 (vascular cell adhesion 
 molecule 1; ab134047), biotinylated anti-ICAM-1 (553251 BD 
Pharmingen), anti-CD31 (Abcam ab28364 and MAB1398Z), 
and anti-active caspase-3 (R&D AF835) anti-mouse antibodies; 
goat anti-rabbit Alexa Fluor 568 and Alexa Fluor 488; goat anti-
hamster IgG Alexa Fluor 647; goat anti-rabbit IgG Alexa Fluor 
568; and chicken anti-rat IgG Alexa Fluor 488 and streptavidin 
Alexa Fluor 488 and Cy3. Slides were mounted with Prolong 
Gold (Life Technologies) after DAPI (4′,6-diamidino-2-phenylin-
dole) staining, and images were captured with a Leica SPE or 
SP5 confocal microscope. Automated quantification of Mac2, 
CD68, SMCa (smooth muscle cell actin), and active caspase-3 
immunofluorescence within atheroma plaques was performed by 
automatic threshold analysis of immunofluorescence images in 
Image J/Fiji.
Lipid Profile Biochemistry
Lipid profiline was performed in serum extracted from cohorts 
of 24-hour-fasted HFD-fed control and miR-217 apoE−/− mice 
with a Dimension RxL Max analyzer.
Echocardiography and Vascular Ultrasound
In vivo ultrasound studies were performed in 2 independent 
aged-matched cohorts of HFD-fed control and miR-217 apoE−/− 
mice. Mice anesthetized with 2% isoflurane mice were exam-
ined by high-frequency ultrasound at 30-µm resolution with a 
VEVO 2100 echography device (VisualSonics, Toronto, Canada). 
Images were analyzed with VEVO 2100 software, version 1.5.0. 
All recordings were made by a cardiac imaging technician blinded 
to animal genotype. Aortic and carotid artery maximal diameters 
were monitored in systole and diastole. For the assessment of left 
ventricular systolic function, parasternal standard 2-dimensional 
long- and short-axis views were acquired. Left ventricular ejection 
fraction and left ventricular end-diastolic volume were obtained 
from the long-axis view. For the study of diastolic function, mitral 
valve flow was evaluated using pulsed-wave Doppler echogra-
phy in the 4-chamber apical view. Assessed parameters included 
early and late diastolic velocity peak waves (E and A, respectively), 
E/A ratio, and pulmonary venous diastolic and systolic profile flow 
from a modified angled 2-dimensional long-axis view.
miR-217 Inhibition by Lentiviral Infection
The miR-217 sponge construct (miR-217SPG) vector, includ-
ing GFP and tandem sequences complementary to miR-217,15 
was cloned into the pHRSIN lentiviral vector.18 Pseudotyped 
lentiviruses were produced by transient calcium phosphate 
transfection of HEK-293T (human embrionic kidney, ATCC 
CRL-1573 cell line) cells. Supernatants containing the len-
tiviral particles were collected 48 hours after removal of the 
calcium phosphate precipitate and ultracentrifuged for 2 hours 
at 26 000 rpm (Optima L-100 XP Ultracentrifuge; Beckman). 
Viruses were suspended in sterile PBS, stored at −80°C, and 
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experiments, 4-month-old male apoE−/− mice were anesthe-
tized (ketamine and xylazine), and a small incision was made to 
expose the right jugular vein. Virus solution (100 µL, 109 par-
ticles/mL in PBS) was inoculated directly into the right jugular 
vein 3 days before initiating the HFD regimen.
Transcriptome Studies in Primary Endothelial 
Cells
Primary microvascular endothelial cells were isolated from 
lungs of control and miR-217 apoE−/− mice by ICAM-2 selec-
tion, which provides a consistent method for obtaining large 
amounts of purified primary vascular endothelial cells. Cells 
were cultured as described above for 7 days in the presence 
of tamoxifen and were selected twice with ICAM-2 magnetic 
beads. Three biological replicates of each genotype were ana-
lyzed, each obtained from a pool of 3 mice. RNA was purified 
from MLEC pellets and treated with DNAse to avoid DNA 
contamination (Qiagen RNAeasy MiniKit). High RNA purity 
and integrity was confirmed by 2100 Bioanalyzer assessment. 
Sequencing libraries were prepared by the Centro Nacional 
de Investigaciones Cardiovasculares Genomics Unit accord-
ing to the manufacturer’s protocol (NEB NEXT Ultra RNAseq 
Library Prep Kit; New England Biolabs) from 100-ng RNA 
per replicate and sequenced in an Illumina HiSeq 2500 plat-
form. Sequencing read quality was assessed with FastQC. 
Illumina adapters were trimmed with Cutadapt 1.7.1, which 
also discarded reads shorter than 30 bp. The resulting reads 
were mapped against the mouse transcriptome (GRCm38 91, 
release 91) and quantified using RSEM v1.3.1. The RSEM 
strandedness reverse parameter was included to calculate 
expression from directional RNA sequencing data. Data were 
then processed with a deferential expression analysis pipeline 
that used the Bioconductor package LIMMA for normalization 
and deferential expression testing. Principal component analy-
sis, performed by comparing the expression level of the set of 
500 genes with the largest SD among samples, was conducted 
to remove samples with the highest variability within each gen-
otype. The gene networks altered by miR-217 expression in 
endothelial cells were analyzed in 4 samples using Ingenuity 
Pathway Analysis software.
Statistical Analysis
Unless stated otherwise, data are expressed as mean±SEM. 
Data were analyzed for normality and equal variance. Statistical 
analysis was performed in GraphPad Prism 7.3, using the 
2-tailed Student t test, the Mann-Whitney nonparametric test, 
or 2-way ANOVA followed by the Bonferroni post hoc test for 
continuous data or the Fisher test for categorical data. For sta-
tistical analysis in human nonagenarian and control cohorts, the 
association between the presence of miR-217 and traditional 
risk factors for which information was available plus lifestyle 
variables was tested by univariate logistic regression analysis. 
Significant variables (P<0.1) were further assessed in a multi-
variate model. The Fuster-Bewat score19,20 predicts individual 
CVD risk based on just 5 variables: BP, physical activity, body 
mass index (BMI), fruit and vegetable consumption, and smok-
ing. We used a pseudo-Bewat score excluding the BP param-
eter because this information was not available in the cohort 
studied.
Data Disclosure
In line with Arteriosclerosis, Thrombosis, and Vascular Biology 
Transparency and Openness Promotion Guidelines, the data 
supporting the findings of this study are available upon rea-
sonable request. Requests for dataset access should be sent 
to V.G. de Yébenes at vgarciay@ucm.es or to A.R. Ramiro at 
aramiro@cnic.es.
RESULTS
Generation of a Mouse Model to Study the 
Function of miR-217 in Endothelial Aging
To assess the association of miR-217 expression with 
physiological endothelial cell aging, we first analyzed the 
expression of miR-217 in primary MLECs aged in vitro. 
miR-217 expression increased gradually as MLECs aged 
and became senescent (Figure IA in the Data Supplement). 
Increased miR-217 expression in aged MLECs was mir-
rored by downregulation of Sirt1 expression. These results 
are consistent with previous findings in human umbilical 
vein endothelial cells10 and indicate that miR-217 regula-
tion of Sirt1 expression is conserved between mouse and 
human endothelial cells. We next analyzed whether vas-
cular miR-217 expression was increased during aging in 
vivo. Aortic miR-217 expression was higher in old mice 
(≥100 weeks old) than in young mice (6–9 weeks old; 
Figure 1A). The expression of miR-217 thus increases 
during physiological endothelial cell aging.
To assess the impact of miR-217 endothelial expres-
sion on cardiovascular physiology in vivo, we generated 
an endothelium-specific and inducible miR-217 knock-in 
mouse model by crossing Rosa26 miR-217 knock-in mice 
(Rosa26miR217ki)15 with the endothelium-specific tamoxifen-
inducible VE-Cad CreERT2TG line16 (Figure 1B). Exami-
nation after tamoxifen administration verified GFP and 
miR-217 expression in the endothelium of VE-Cad Cre-
ERT2TG/+; Rosa26miR217ki/+ mice (hereafter called miR-217KI 
mice) and its absence in VE-Cad CreERT2TG/+; Rosa26+/+ 
control mice (Figure 1C and 1D; Figure IB in the Data 
Supplement). Analysis of Sirt1 expression showed that the 
increased endothelial expression of miR-217 in miR-217KI 
mice reduced Sirt1 expression in vivo (Figure 1D).
These results demonstrate that miR-217 expression 
increases during physiological aging and that endothelial 
miR-217 expression downregulates the metabolic sen-
sor Sirt1 in vivo.
Endothelial miR-217 Expression Leads to 
Endothelial Dysfunction
To assess the pathophysiological consequences of endothe-
lial miR-217 expression, we tested the endothelial function 
of miR-217KI mice in the apoE−/− proatherogenic back-
ground. Control apoE−/− mice (VE-Cad CreERT2TG/+; Rosa-
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CreERT2TG/+; Rosa26miR217KI/+; apoE−/−) were injected with 
tamoxifen to induce Cre-dependent endothelial expression 
and fed an HFD to promote endothelial stress. Analysis of 
miR-217KI apoE−/− mouse aorta revealed a reduction in 
endothelial Sirt1 expression (Figure IC in the Data Supple-
ment) similar to that observed in the wild-type background 
(Figure 1D). Since Sirt1 is a regulator of eNOS activity in 
endothelial cells12 and eNOS-derived NO is essential for 
vascular function, we analyzed NO production and the con-
tractile and relaxant responses of miR-217KI apoE−/− mouse 
arteries. We examined the aorta as a conductance artery in 
which endothelium-induced relaxation is highly NO depen-
dent and the mesenteric arteries as an example of resis-
tance vessels in which NO makes a minor contribution.21,22 
Aortic overexpression of endothelial miR-217 resulted in 
reduced eNOS activity, as shown by reduced acetyl cho-
line–induced NO production (Figure 2A) and impaired 
endothelium-dependent vasodilation (Figure 2B). More-
over, vasodilation in response to the NO donor diethylamine 
NONOate was similar in control apoE−/− and miR-217KI 
apoE−/− mice (Figure 2B), suggesting that the endothelial 
dysfunction in miR-217KI apoE−/− mouse aorta is due to 
deficient NO production by endothelium rather than altered 
NO signaling in the underlying smooth muscle. Interestingly, 
neither mouse group showed differences in vasoconstrictor 
responses (Figure ID in the Data Supplement). Analysis of 
vascular function in mesenteric resistance arteries revealed 
similar acetylcholine-induced relaxation in arteries from both 
mouse groups (Figure IE in the Data Supplement); however, 
phenylephrine-induced mesenteric artery vasoconstriction 
was significantly enhanced in mice overexpressing miR-
217 in the endothelium (Figure 2C). These results indicate 
that endothelial miR-217 expression causes deficient NO 
production and endothelial dysfunction.
To determine whether miR-217 expression affects ves-
sel size in vivo, we measured the lumen diameters of arter-
ies by ultrasound imaging. Compared with vessels from 
control animals, vessels of miR-217KI apoE−/− mice had 
smaller lumen diameters during systole and diastole (Fig-
ure 2D; Figure IF in the Data Supplement). In addition, miR-
217 overexpression in HFD-fed apoE−/− mice resulted in 
higher systolic and diastolic BPs (Figure 2E), most likely as 
a consequence of impaired endothelial function.
To assess whether miR-217–induced vascular dys-
function could be reverted with a vasoprotective treat-
ment, we analyzed BP and carotid lumen diameter in 
control apoE−/− and miR-217KI apoE−/− mice after admin-
istration of resveratrol—a widely used multifunctional 
compound that stimulates Sirt1 and eNOS (Figure IG in 
the Data Supplement).23–25 Resveratrol reverted the miR-
217–induced BP increase and carotid vasoconstriction 
in apoE−/− mice (Figure 2F).
Figure 1. Generation of an endothelium-specific mouse model to study the function of miR-217 in vivo.
A, miR-217 expression is associated with endothelial aging. qPCR analysis of miR-217 expression in aortas of young (6–9 wk old) and aged (2 
y old) C57/Bl6 mice. B, Constructs used to generate the endothelium-specific miR-217 mouse model. In ROSA26miR217KI mice, the miR-217 
precursor construct is inserted within the Rosa26 locus, where it is preceded by a LoxP-flanked transcriptional stop site. ROSA26miR217KI 
mice were crossed with endothelium-specific and tamoxifen-inducible VE-Cad (VE-cadherin) Cre ERT2TG mice to generate miR-217KI mice. C, 
Immunohistochemical detection of GFP expression in CD31+ aortic endothelial cells of VE-Cad CreERT2 control mice (miR-217+/+ VE-Cad 
CreERT2TG/+) and miR-217–overexpressing miR-217KI mice (miR-217KI/+ VE-Cad CreERT2TG/+) after tamoxifen (TMX) injection. D, qPCR analysis 
of aortic miR-217 and Sirt1 (silent information regulator 1) expression in control and endothelium-specific miR-217–overexpressing miR-217KI 
mice 12 wk post-TMX injection. Each dot represents an individual mouse. CD indicates cluster of differentiation; GFP, green fluorescent protein; 
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Figure 2. miR-217 expression impairs endothelial physiology.
A, Acetylcholine (ACh)-induced NO production in aortas from male control apoE−/− mice (miR-217+/+ VE-Cad CreERT2TG/+ apoE−/−) and miR-
217KI apoE−/− mice (miR-217KI/+ VE-Cad CreERT2TG/+ apoE−/−) fed with HFD for 12 wk. B, Concentration-response curves to ACh or the NO 
donor diethylamine NONOate (DEA-NO) and maximal relaxation to ACh of aorta from male control apoE−/− mice and miR-217KI apoE−/− mice. 
C, Concentration-response curve to phenylephrine (Phe) of mesenteric resistance arteries, from male control apoE−/− mice and miR-217KI 
apoE−/− mice. *P<0.05 vs control apoE−/− mice by 2-way ANOVA followed by Bonferroni post-test. Maximal relaxation was analyzed by the 
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Overall, these results show that increased expression 
of miR-217 in the endothelium under proatherogenic 
stress conditions disturbs endothelium-derived NO pro-
duction and impairs vascular physiology in vivo.
Endothelial miR-217 Expression Accelerates 
Atherosclerosis and Coronary Lesion 
Development
To study the role of endothelial miR-217 expression in 
atherogenesis, we analyzed the presence and quantity of 
lipid-rich atherosclerotic plaques in miR-217KI apoE−/− and 
control apoE−/− mice in aortic root cross sections. Endothe-
lial miR-217 overexpression in apoE−/− mice increased the 
size of atherosclerotic plaques in the aortic root (Figure 3A 
and 3B; Figure IIA in the Data Supplement). Plaques in 
miR-217KI apoE−/− mice showed no significant changes in 
macrophage content (Figure 3C; Figure IIB and IIC in the 
Data Supplement) but were more advanced and had larger 
necrotic cores and lower collagen content than plaques 
in control apoE−/− mice (Figure 3D). An increased size of 
the plaque necrotic core can be associated with high rates 
of apoptosis,26 and we found significantly elevated active 
caspase-3 staining in plaques isolated from miR-217KI 
apoE−/− mice (Figure 3E). Moreover, miR-217KI apoE−/− 
mice had significant atherosclerosis in the coronary arteries 
(Figure 3E), whereas coronary artery atherosclerosis was 
minimal in control apoE−/− mice (Figure 3F), as reported in 
previous studies of HFD-fed apoE−/− mice.27,28 miR-217KI 
apoE−/− and control apoE−/− mice showed no significant 
differences in the aortic expression of the proinflammatory 
molecules Icam, IL1β, IL6, and TNFα (Figure IID in the Data 
Supplement), the expression of endothelial activation mol-
ecules Vcam-1 and Icam-1 in atheroma plaques (Figure IIE 
in the Data Supplement), or the content of circulating lipids 
and cholesterol (Figure IIF in the Data Supplement). These 
results suggest that endothelial miR-217 expression does 
not alter endothelial cell activation or promote changes in 
lipid biosynthesis or retention mechanisms.
Endothelial miR-217 expression thus aggravates 
atherogenesis development in apoE−/− mice, resulting 
in the generation of larger, more advanced aortic ath-
erosclerotic plaques and the development of coronary 
atherosclerosis.
Endothelial miR-217 Expression Triggers 
Impaired Left Ventricular Function
To determine whether endothelial dysfunction and 
coronary artery disease caused by endothelial miR-
217 expression compromise cardiac performance, we 
conducted echocardiographic studies of HFD-fed control 
and miR-217KI apoE−/− mice. miR-217–overexpressing 
mice had altered left ventricular diastolic function, char-
acterized by reduced left ventricular relaxation. Transmi-
tral Doppler echocardiography revealed a reduced ratio of 
peak velocity flow in early diastole (E wave) to the peak 
velocity flow in late diastole caused by atrial contraction (A 
wave; E/A ratio; Figure 4A), whereas pulmonary venous 
Doppler echocardiography detected reduced diastolic (D2 
wave) pulmonary venous flow (Figure 4B). Moreover, miR-
217KI apoE−/− mice also showed left ventricular systolic 
dysfunction, revealed by a reduced left ventricular ejection 
fraction in M-mode long-axis echocardiography studies 
(Figure 4C; Movie I in the Data Supplement), consistent 
with a reduction in left ventricular contractile function in 
these mice. The reduced contractility in miR-217KI apoE−/− 
mice was independent of changes in the left ventricular 
diastolic diameter, wall thickness (posterior wall thickness), 
and interventricular wall septal thickness (not shown).
miR-217 Inhibition Improves Vascular Contractile 
Function and Reduces Atherosclerotic 
Development in Proatherogenic Mice
The ability of endogenous miR-217 inhibition to improve 
endothelial function in proatherogenic conditions was 
assessed in miR-217 loss-of-function assays in HFD-fed 
apoE−/− mice. For this analysis, we generated miR-217SPG 
(Figure 5A), in which miR-217–complementary sequences 
were cloned in tandem within the 3′UTR (the three prime 
untranslated region) of a reporter gene, thus functioning 
as competitive inhibitors for miR-217 binding to its endog-
enous binding sites.15,29 The aorta was transduced by injec-
tion of control or miR-217SPG lentivirus into the jugular 
vein of apoE−/− mice (Figure 5B),18,30 and aortic contractile 
properties were assessed in isometric tension studies. miR-
217 inhibition by miR-217SPG slightly increased endo-
thelium-dependent vasodilation and significantly reduced 
phenylephrine-induced aortic contraction, without modify-
ing diethylamine NONOate–induced relaxation (Figure 5C 
and 5D). The NOS inhibitor L-NAME increased phenyleph-
rine responses in arteries from both miR-217SPG–trans-
duced and control lentivirus-transduced mice (Figure 5D). 
The effect of L-NAME was greater in miR-217SPG–
transduced aortas than in controls, as shown by the greater 
L-NAME–induced increase in Emax (control, 123.1±9.2%; 
miR-217SPG, 170.8±18%; P<0.05), indicating more 
NO availability. In addition, we found that transduction of 
apoE−/− mice with miR-217SPG lentivirus reduced HFD-
induced atherosclerotic plaque development in the aortic 
root (Figure 5E).
Figure 2 Continued. (top) and right carotid lumen diameter (bottom) in control and miR-217 apoE KO (knockout) mice fed with HFD for 
12 wk. E, Systolic and diastolic blood pressure (BP) in control apoE−/− and miR-217KI apoE−/− mice fed with HFD for 10 to 11 wk. F, BP and 
carotid diameters in control apoE−/− and miR-217KI apoE−/− mice fed an HFD before and 1 wk after resveratrol (RESV) administration. Each dot 
represents an individual mouse. Systolic BP unpaired t test P (miR-217KI apoE−/− vs control apoE−/−+resveratrol P=0.059; miR-217KI apoE−/− 
vs miR-217KI apoE−/−+resveratrol P=0.14; control apoE−/−+resveratrol vs miR-217KI apoE−/−+resveratrol P=0.8) *P<0.05, **P<0.01, ns (not 
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Figure 3. Endothelial miR-217 expression promotes atherosclerosis and coronary artery disease.
A and B, Quantification of atherosclerotic lesions by red oil staining of aortic sinus and proximal aorta heart sections in control apoE−/− mice 
(miR-217+/+ VE-Cad CreERT2TG/+ apoE−/−, n=12) and miR-217KI apoE−/− mice (miR-217 KI/+ VE-Cad CreERT2TG/+ apoE−/−, n=9) fed an HFD 
for 7 wk. A, Representative red oil–stained aortic sinus cross sections from control apoE−/− and miR-217KI apoE−/− HFD-fed mice (left) and 
quantification of atherosclerotic lesion area through the aortic sinus and ascending aorta (right). Each data point represents mean lesion area 
at the specified distance from the aortic sinus. B, Total atherosclerotic lesion volume in aortic sinus of control apoE−/− and miR-217KI apoE−/− 
mice, determined by calculating the area under the curve for each mouse from lesion area graphs (mm2; Figure II in the Data Supplement). C, 
Macrophage infiltration area quantified by Mac2 immunofluorescence in atherosclerotic lesions from control apoE−/− and miR-217KI apoE−/− 
HFD-fed mice. Each data point represents total Mac2+ area in the aortic sinus cross section of an individual mouse. D, Necrotic core (NC) 
content of atherosclerotic lesions determined by Masson trichrome staining on aortic sinus cross sections in HFD-fed control apoE−/− (n=9) 
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These results thus show that inhibition of miR-217 in 
the vasculature improves vascular function and reduces 
atherosclerotic development, revealing the therapeutic 
potential of endothelial miR-217 inhibition for the treat-
ment of aging-related CVD.
miR-217 Expression Inhibits eNOS Stimulatory 
Pathways in Endothelial Cells
To gain mechanistic insight into the function of miR-
217 in endothelial gene expression, we performed 
RNA sequencing transcriptome analysis on endothelial 
cells from miR-217KI apoE−/− and control apoE−/− mice 
(Table IA in the Data Supplement; Figure IIIA in the Data 
Supplement). miR-217 expression altered the vascu-
lar function signature, with changes in gene expression 
that promote decreased arterial relaxation and increased 
BP (Figure 6A; Table ID and IE in the Data Supplement; 
Figure IIIB in the Data Supplement). Detailed pathway 
enrichment analysis showed that miR-217 modifies gene 
pathways important in endothelial biology such as cell sig-
naling, leukocyte adhesion and endothelial permeability, 
and extracellular matrix and collagen-mediated pathways 
(Figure 6B; Table IB and IC in the Data Supplement). 
Moreover, we found that miR-217 inhibits signaling path-
ways that activate eNOS (APLNR [apelin receptor] signal-
ing, VEGF signaling [VEGFR (VEGF receptor) and VEGF], 
adenylyl cyclase, and the lysophosphatidic acid receptor 
[LPAR]31,32; Figure 6C; Table IB in the Data Supplement) 
through direct and secondary target gene regulation (Fig-
ure IIIC and IIID in the Data Supplement; Table IG through 
II in the Data Supplement). To validate these transcrip-
tome results, we analyzed the expression of key eNOS 
stimulatory genes by quantitative real-time polymerase 
chain reaction in MLECs isolated from miR-217KI apoE−/− 
or control apoE−/− mice. This analysis confirmed robust 
downregulation in miR-217KI apoE−/− MLECs of multiple 
genes, including the APLNR (an eNOS activator via AKT) 
Figure 4. miR-217 expression promotes left ventricular dysfunction.
A, Left ventricular diastolic function assessed as the ratio of Doppler-detected peak early diastolic velocity (E′) to peak late diastolic velocity (A′) 
in control apoE−/− mice (miR-217+/+ VE-Cad CreERT2TG/+ apoE−/−) and miR-217KI apoE−/− mice (miR-217KI/+ VE-Cad CreERT2TG/+ apoE−/−) fed 
an HFD for 8 wk. Right, Representative echocardiography images. B, D2 pulmonary vein velocity in control apoE−/− and miR-217KI apoE−/− mice 
fed an HFD for 8 wk. C, Left ventricular ejection fraction in control apoE−/− and miR-217KI apoE−/− mice determined by echocardiography after 10 
wk on an HFD. Data are from 2 independent experiments. Each dot represents an individual mouse. *P<0.05, **P<0.01 by unpaired t test (A–C). 
apoE indicates apolipoprotein E; LVID;d, left ventricular internal diameter in diastole; and LVID;s, left ventricular internal diameter in systole.
Figure 3 Continued. E, Cellular apoptosis in atheroma plaques quantifed by active caspase-3 immunofluorescence in aortic sinus cross 
sections from control apoE−/− and miR-217KI apoE−/− HFD-fed mice. Each data point represents the proportion of active caspase-3 area per 
lesion in an individual mouse. Green, CD68; red, caspase-3. Top, Representative images of the quantification shown in the lower graphs. F, 
Atheroma plaque quantification in the left coronary artery by red oil staining of aortic sinus cross sections in 3 independent experiments (total 
n=26 control apoE−/− and n=29 miR-217KI apoE−/− mice). Top, Representative images. Charts show the proportion of mice with atherosclerosis 
(≥20% of plaque in lumen) in the left anterior descending (LAD) coronary artery (left) and the proportion with occlusive plaques (≥50% of 
plaque in lumen) in the circumflex (CX) coronary artery. Error bars show the SD in the quantification between experiments. *P<0.05, **P<0.01, 
****P<0.0001 by unpaired t test (A–D). apoE indicates apolipoprotein E; CD, cluster of differentiation; DAPI, 4′,6-diamidino-2-phenylindole; 
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and VEGFR1 (Flt1; the receptor for VEGFA, VEGFB, and 
placental growth factor and an initiator of the PI3K-Akt-
eNOS signaling pathway). We also detected modest down-
regulation of genes of other eNOS-activating pathways, 
including LPAR, ADCY2, and Sirt1. Endothelial cells from 
miR-217KKI apoE−/− mice also showed significant down-
regulation in the expression of Nos3—the gene encod-
ing eNOS (Figure 6D). Consistent with these results, we 
found that miR-217SPG–lentivirus-mediated inhibition of 
miR-217 in apoE−/− MLECs resulted in the upregulation 
of eNOS activator genes in the apelin and VEGF signaling 
pathways (Figure IIIE in the Data Supplement).
miR-217 thus regulates a hub of endothelial physiol-
ogy pathways and triggers a coordinated downregulation 
of eNOS stimulatory genes, resulting in eNOS pathway 
inhibition in endothelial cells.
Figure 5. Inhibition of endogenous miR-217 improves vascular contractile function and reduces atherosclerosis development.
A, miR-217-Sponge (miR-217SPG) construct used for vascular miR-217 inhibition. Four miR-217 complementary sites, separated by 4-nt 
spacers, were placed downstream of GFP in the pHRSIN lentiviral vector. B, CD31 and GFP immunostaining in ascending aorta sections 
of apoE−/− mice inoculated through the jugular vein with control or miR-217SPG pHRSIN lentivirus. C, Concentration-response curves to 
acetylcholine (left) and the NO donor diethylamine NONOate (DEA-NO; right) and (D) effect of L-NAME on the concentration-response curve 
to phenylephrine (Phe), in aortic segments from male control and miR-217SPG–infected apoE−/− mice fed HFD for 12 wk. E, Red oil staining 
analysis of atherosclerotic lesion area in aortic sinus and ascending aorta sections from control and miR-217SPG–infected apoE−/− mice 
fed an HFD for 12 wk. Left, Representative red oil–stained cross sections 320 µm from the aortic sinus in control and miR-217SPG–infected 
mice. *P<0.05 by unpaired t test or ANOVA. 3'UTR indicates the three prime untranslated region; Ach, acetylcholine; apoE, apolipoprotein E; 
CD, cluster of differentiation; GFP, green fluorescent protein; L-NAME, N (gamma)-nitro-L-arginine methyl ester; LTR, long terminal repeat; and 
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Plasma miR-217 Is a Biomarker of 
Cardiovascular Aging in Humans
To determine whether miR-217 is associated with 
human vascular aging, we analyzed miR-217 expression 
in the context of some of the best characterized cardio-
vascular risk factors, including age, BMI, and lifestyle 
risks. Analysis of miR-217 expression in a collection of 
plasma samples from nonagenarian and young (<50 
years old) individuals revealed a higher proportion of 
Figure 6. Effect of miR-217 on endothelial transcriptome.
Study of gene networks regulated by miR-217 in primary mouse endothelial cells. A, Pathway activity prediction in significantly changed 
Cardiovascular Development and Functions analysis of RNA sequencing (RNA-Seq) gene expression quantification in endothelial cells isolated 
from lungs (MLECs) of miR-217KI apoE−/− or control apoE−/− mice. Pathway activity prediction is shown with a color code (blue, inhibited; orange, 
activated). B, Circus plot showing the fold change expression (logFC; left) of genes of significantly changed cardiovascular-related pathways 
(1–5; right). Gene expression was quantified by RNA-Seq in MLECs derived from miR-217KI apoE−/− or control apoE−/− mice. C, Ingenuity 
canonical pathway analysis from significantly changed pathways grouped in the 5 general cardiovascular-related categories shown in B. Pathway 
activity prediction is shown with a color code (blue, inhibited; orange, activated). P values were corrected for multiple testing using the Benjamini-
Hochberg (B–H) false discovery rate. D, qPCR analysis of gene expression in control apoE−/− and miR-217KI apoE−/− MLECs. Expression was 
normalized to GAPDH. ADCY2 indicates adenylate cyclase 2; APLNR, apelin receptor; apoE, apolipoprotein E; EC, endothelial; ECM, extracellular 
matrix; eNOS, endothelial NO synthase; LPAR1, lysophosphatidic acid receptor-1; qPCR, quantitative polymerase chain reaction; SIRT1, silent 
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individuals expressing miR-217 among the nonage-
narian group (Figure 7A), indicating that plasma miR-
217 expression is an aging-associated biomarker in 
humans. Analysis of the association between plasma 
miR-217 lifestyle variables revealed a lower rate of 
miR-217 expression among individuals with lower risk 
habits (physical activity, moderate alcohol consumption, 
and health dietary habits such as weekly consumption 
of fruit and vegetables and low intake of processed 
meat; Figure 7B). Moreover, individuals with detectable 
plasma miR-217 tended to have a higher BMI (Fig-
ure 7C), whereas mean BMI did not differ significantly 
between young individuals and nonagenarians (P=0.46; 
Figure IVA in the Data Supplement). These results are 
consistent with the association of increased vascular 
miR-217 expression with age (Figure 1B) and HFD 
(Figure IVB in the Data Supplement) in mice, and we 
found that increased vascular miR-217 expression in 
mice was associated with the presence of miR-217 in 
serum (Figure IVC in the Data Supplement). Univariate 
logistic regression to identify variables associated with 
plasma miR-217 expression in the young and nonage-
narian cohorts identified a negative correlation between 
plasma miR-217 expression and the pseudo-BEWAT 
cardiovascular prediction score (Table 1). A subsequent 
multivariate logistic regression model based on noncol-
linear variables (Tables 2 and 3) revealed that young 
individuals without miR-217 had higher pseudo-BEWAT 
risk scores, which translates into better cardiovascular 
health (b=−0.7, P=0.017; Table 3). In agreement with 
these results and with recent reports,33 we found that 
plasma miR-217 levels are increased in individuals with 
coronary atherosclerosis (Figure 7D).
Overall, our results show that the presence of miR-
217 in plasma is a biomarker of aging and a predictor of 
cardiovascular risk in humans.
DISCUSSION
In this study, we have generated the first animal model 
assessing the role of an aging-induced miRNA in 
endothelial pathophysiology. Previous reports identified 
miR-217 as the most highly induced miRNA in human 
endothelial cells during in vitro aging.10 Our results show 
that miR-217 expression increases during physiologi-
cal endothelial cell aging and demonstrate that plasma 
miR-217 is a biomarker of human aging associated 
with elevated cardiovascular risk. It remains uncertain 
whether the aging-related increase of plasma miR-
217 in nonagenarian individuals is exclusively due to 
increased endothelial cell expression; however, we found 
that endothelium-specific miR-217 expression in mice 
results in increased serum miR-217. The cellular mech-
anisms responsible for circulating miR-217, whether 
involving exosomal or other paracrine secretion routes, 
remain to be explored.
In agreement with previous reports in human vein 
endothelial cells,10 we found that miR-217 downregulates 
Sirt1 expression in vivo. However, the global impact of 
miR-217 on the endothelial transcriptome had not been 
addressed before. We found that miR-217 expression dis-
rupts endothelial physiology, dysregulating the expression 
of various signaling pathways important for endothelial 
function. Remarkably, we found concurrent downregula-
tion of various signaling pathways leading to eNOS acti-
vation, including the apelin and VEGF pathways,31,32 and 
of eNOS expression. In agreement with our transcriptome 
data and the key role of endothelial-derived NO production 
in the vasculature,13,14 we found that endothelial miR-217 
overexpression had a notable impact on vascular homeo-
stasis.34–38 Consistent with diminished eNOS activity and 
expression, endothelial-dependent NO production was 
reduced in the aortas of miR-217KI apoE−/− mice, and this 
was accompanied by parallel functional changes. Never-
theless, our transcriptomic data suggest that in addition to 
the defects caused by a diminished eNOS expression and 
activity, miR-217 regulates through direct targing a hub of 
endothelial functions (including extracellular matrix, colla-
gen-mediated, and actin intracellular signaling pathways) 
that are likely to contribute to the observed phenotype.15 
Further research is warranted into how these miR-217 
targets contribute to the impact of miR-217 expression 
on endothelial physiology and CVD.
Endothelial miR-217 expression resulted in several 
clinically relevant cardiovascular disorders in apoE−/− mice, 
including endothelial dysfunction, increased BP, exacer-
bated atherosclerosis development, coronary artery dis-
ease, and left ventricular systolic and diastolic dysfunction. 
Diminished eNOS expression promotes endothelial dys-
function,12,39 which is causally linked to reduced endothelial 
NO production40,41; we, therefore, postulate that endothe-
lial dysfunction in miR-217 mice is directly caused by miR-
217–induced eNOS-NO pathway downregulation (see 
Graphic Abstract). Interestingly, the mesenteric arteries of 
miR-217KI apoE−/− mice showed no alteration in vascu-
lar endothelial function but had an enhanced contractile 
response to phenylephrine; this is likely related to the minor 
contribution of NO to endothelium-dependent relaxation in 
this vascular bed. Our data further show that administration 
of resveratrol—a multifunctional vasoprotective treatment 
that stimulates Sirt1 and eNOS,23 reverts the vasoconstric-
tion and increased BP found in miR-217 mice, revealing 
a protective effect of resveratrol on aging-related miR-
217–induced vascular dysfunctions.
Most cardiovascular abnormalities seen in miR-217KI 
apoE−/− mice (high BP, atherosclerosis, and left ventricular 
diastolic dysfunction) are closely interrelated40,42 and can be 
triggered by endothelial dysfunction. We, therefore, propose 
that miR-217–induced endothelial dysfunction is the first step 
in a chain of events leading to atherosclerosis and CVD (see 
Graphic Abstract). Previous research has shown that apoE−/− 
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with age.43 Endothelial expression of the aging-induced 
miRNA miR-217 thus recapitulates various cardiovascular 
phenotypes associated with aging in the apoE-deficient pro-
atherogenic mouse model.
Although miR-217–induced endothelial aging and 
dysfunction can lead to atherosclerosis, raised BP, and 
left ventricular diastolic dysfunction, endothelial dys-
function is unlikely to be the primary cause of the left 
ventricular systolic dysfunction found in miR-217KI 
apoE−/− mice. A more likely cause is the development 
of significant coronary atherosclerosis, which, together 
with increased BP, is one of the main causes of cardiac 
systolic dysfunction.44,45 Interestingly, apoE−/− mice are 
generally resistant to coronary artery atherosclerosis, 
but the combination of apoE deficiency with additional 
genetic alterations has enabled the generation of mouse 
models of coronary artery disease. This is the case for 
mutations affecting HDL (high-density lipoprotein) sig-
naling via SR-B1 (scavenger receptor, class B type 1), 
which lead to eNOS activation.27,46 It is thus likely that 
deficient eNOS activation contributes to coronary ath-
erosclerosis in miR-217KI apoE−/− mice, and we, there-
fore, propose that left ventricular systolic dysfunction in 
miR-217KI apoE−/− mice is secondary to coronary artery 
disease and increased BP in this proatherogenic mouse 
model (see Graphic Abstract).
Figure 7. Plasma miR-217 is a biomarker of aging associated with cardiovascular risk in humans.
A, Plasma miR-217 is a biomarker of human aging. The proportion of individuals with detectable plasma miR-217 was determined by qPCR in 
samples from young healthy control individuals (<50 y old; n=42) and nonagenarian individuals (n=41). B, miR-217 is a biomarker for cardiovascular 
aging. The proportion of individuals with detectable miR-217 in plasma stratified by lifestyle habits in young control and nonagenarian cohorts or only 
in the young cohort. C, Plasma miR-217 is associated with increased body mass index (BMI). BMI values are shown for individuals with detectable 
or no detectable plasma miR-217 in cohorts of sex-matched young healthy controls (<50 y old) and nonagenarian women. The gray line indicates 
overweight (BMI, ≥25). Unpaired t test P=0.05. D, Serum miR-217 is a biomarker of atherosclerosis in humans. The chart shows the proportions of 
healthy controls (n=34) and individuals with coronary atherosclerosis (n=32) with detectable miR-217 in plasma determined by quantitative real-time 
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The major implication of left ventricular dysfunction 
in heart failure42,47 underscores the clinical implications 
of our findings on the contribution of miR-217 expres-
sion to the development of CVD. Interestingly, miR-217 
is among the most upregulated miRNAs in the hearts 
of chronic heart failure patients,33 and overexpression of 
miR-217 in mouse hearts aggravates aortic constriction–
induced cardiac hypertrophy and dysfunction.48 Together, 
these results suggest that the increased expression of 
miR-217 in vascular and cardiac tissues is deleterious to 
cardiovascular function.
By establishing that miR-217 inhibition in the vascu-
lature of proatherogenic mice partially protects vascular 
function and reduces atherosclerosis, our results sug-
gest that modulation of miR-217 expression or activity 
has therapeutic potential. Further studies of miR-217 
inhibition in other animal models of CVD will be required 
to establish whether the inhibition of miR-217 in the vas-
culature has therapeutic potential for the treatment of 
left ventricular systolic or diastolic dysfunction.
Our analysis of human cohorts reveals a remarkable 
association of plasma miR-217 with well-established 
cardiovascular risk factors, including low physical activity, 
poor dietary habits, and high BMI. This trend is reflected 
in a significant association of plasma miR-217 with a 
validated cardiovascular risk factor score predictor in 
healthy control individuals, establishing miR-217 as a 
biomarker of cardiovascular aging in humans.
Overall, our results reveal the role of an aging-induced 
miRNA in CVD and provide a rationale for the design of 
therapeutic strategies for aging-related cardiovascular 
disorders based on the inhibition of endothelial miR-217 
expression.
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Table 1. Univariate Logistic Regression Model for All Lifestyle and Cardiovascular Risk Factors 
Available in the Study
Variable Contrast β SE P Value
Physical activity Yes vs no −1.28402 0.544789 0.018428
Age  0.022716 0.00972 0.019433
BMI  0.127457 0.058166 0.028432
Moderate alcohol Yes vs no −1.12678 0.579009 0.051648
CVR (pBEWAT)  −0.18995 0.109747 0.083493
Current smoker No vs yes −0.48551 0.56543 0.390533
Sex Male vs female −0.10821 0.715091 0.879717
All individuals (young and nonagenarians) are considered. CVR indicates cardiovascular risk; and pBEWAT, pseudo-Bewat score.
Table 2. Lifestyle Multivariate Logistic Regression Model 
for Nonredundant Variables Significantly Associated With 
the Presence of miR-217 in Plasma in the Univariate Analysis
Coefficient β SE P Value
Intercept −0.50351 1.268993 0.691529
Age 0.016334 0.011881 0.169193
Moderate alcohol −0.40822 0.716889 0.569067
CVR (pBEWAT) −0.12799 0.117126 0.274514
All individuals (young and nonagenarians) are considered. Table 1, P<0.1. CVR 
indicates cardiovascular risk; and pBEWAT, pseudo-Bewat score.
Table 3. Multivariate Logistic Regression Model for Non-
redundant Variables Significantly Associated With the Pres-
ence of miR-217 in Plasma in the Univariate Analysis
Coefficient β SE P Value
Intercept 6.914259973 4.277591 0.10601
Age −0.060743619 0.074743 0.416391
Moderate alcohol −0.597295451 0.895068 0.504569
CVR (pBEWAT) −0.701310777 0.294704 0.017326
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